News

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...
In just over a year since its launch, India’s National Sickle Cell Elimination Mission (NSCEM) is already demonstrating a ...
The intricate, hidden processes that sustain coral life are being revealed through a new microscope developed by scientists ...
The intricate, hidden processes that sustain coral life are being revealed through a new microscope developed by scientists ...
A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...
Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.